Related Experiment Video
Updated: Jul 13, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The copious capabilities of non-coding RNAs in cancer regulation, diagnosis and treatment
Aideen McCabe1, Oza Zaheed1, Magdalina Derlipanska2
1School of Biochemistry and Cell Biology, College of Science, Engineering and Food Science, University College Cork, Ireland; The SFI Centre for Research Training in Genomics Data Science, Ireland.
Abstract:
Globally, cancer is one of the leading causes of mortality, accounting for 10 million deaths per year. Non-coding RNAs (ncRNAs) play integral and diverse roles in cancer, possessing the ability to both promote oncogenesis and impede tumor formation. This review discusses the various roles of microRNAs, transfer RNA-derived small RNAs, long non-coding RNAs and lncRNA-derived microproteins in cancer progression and prevention. We highlight the diagnostic and therapeutic potential of these ncRNAs, with a particular focus on detection in liquid biopsies and targeting of ncRNAs with small inhibitory molecules. Ultimately, the biological functions of cancer-associated ncRNAs, as well as the development of ncRNA-based technologies, are compelling areas for further research, holding the possibility of revolutionizing cancer treatment and diagnosis.
Insights
Non-coding RNAs (ncRNAs) play crucial roles in cancer development and prevention. Research into ncRNA diagnostics and therapeutics, including liquid biopsies, offers revolutionary potential for cancer treatment.
Area of Science:
- Oncology and Molecular Biology
- Genetics and Genomics
Background:
- Cancer remains a leading global cause of death, with 10 million annual fatalities.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their dual roles in promoting or inhibiting cancer.
Approach:
- This review synthesizes current knowledge on diverse ncRNA types, including microRNAs, tRNA-derived small RNAs, and long non-coding RNAs.
- It examines their involvement in cancer progression and prevention mechanisms.
Key Points:
- Specific ncRNAs like microRNAs and lncRNAs are implicated in oncogenesis and tumor suppression.
- Diagnostic potential lies in detecting ncRNAs in liquid biopsies.
- Therapeutic strategies focus on targeting ncRNAs with small inhibitory molecules.
Conclusions:
- ncRNAs represent a promising frontier for novel cancer diagnostics and therapeutics.
- Further research into cancer-associated ncRNAs and ncRNA-based technologies could revolutionize patient care.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Experimental RNAi
Types of RNA
RNA Performs Diverse...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

